Prostate Cancer Detection and Screening

Introduction to Prostate Cancer Screening

Approximately 1 in 7 men with PSA levels below 4.0 ng/mL will have prostate cancer, according to the National Comprehensive Cancer Network 1
The National Comprehensive Cancer Network recommends considering factors beyond PSA, including patient age and prostate volume, for risk stratification 1

PSA tests can produce "false-negative" results, meaning they can be normal even when prostate cancer is present, as stated by the National Comprehensive Cancer Network 1
The higher a man's PSA level is, the more likely he is to have prostate cancer, as reported by the National Comprehensive Cancer Network 1
PSA is not cancer-specific but prostate-specific, meaning other conditions like benign prostatic hyperplasia (BPH) and prostatitis can also cause PSA elevation, according to The Journal of Urology 2

Factors to consider beyond PSA include patient age, prostate volume, family history of prostate cancer, African descent, and changes in PSA over time, as recommended by the National Comprehensive Cancer Network and BMJ [1] [3]
Men with steady rises in PSA are more likely to have cancer, and rapid PSA rises may indicate more life-threatening cancer, according to the National Comprehensive Cancer Network 1

Prostate biopsy remains the definitive test for diagnosing prostate cancer, not the PSA test, as stated by the National Comprehensive Cancer Network 1
Biopsies aren't perfect and can sometimes miss cancer when present, according to the National Comprehensive Cancer Network 1

Given the limitations of PSA testing, shared decision making is essential when considering prostate cancer screening, as recommended by BMJ 3
Men should be informed about both potential benefits and harms of PSA screening, including false positives, unnecessary biopsies, and overtreatment, as reported by BMJ 3
The small potential benefit of prostate cancer screening corresponds to preventing, at most, 1 death from prostate cancer per 1000 men screened after 11 years of follow-up, according to Annals of Internal Medicine 5